Global IBS-C Drugs Market Analysis 2015-2019 and Forecast 2020-2025
- Report Code : 99S1336380
- Published On: Jan, 2020
- Category : Healthcare & Pharma
- Pages : 126
-
The global IBS-C Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of IBS-C Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
-
With tables and figures helping analyze worldwide market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Industry Overview1.1 IBS-C Drugs Industry
Figure IBS-C Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of IBS-C Drugs1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of IBS-C Drugs
1.2.2 Downstream
Table Application Segment of IBS-C Drugs
Table Global IBS-C Drugs Market 2015-2025, by Application, in USD Million1.3 Cost Analysis
2 Industry Environment (PEST Analysis)2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 IBS-C Drugs Market by Type3.1 By Type
3.1.1 Linaclotide
Table Major Company List of Linaclotide
3.1.2 Lubiprostone
Table Major Company List of Lubiprostone
3.1.3 Osmotic Laxatives
Table Major Company List of Osmotic Laxatives
3.1.4 Stimulant Laxatives
Table Major Company List of Stimulant Laxatives
3.1.5 Others
Table Major Company List of Others3.2 Market Size
Table Global IBS-C Drugs Market 2015-2019, by Type, in USD Million
Figure Global IBS-C Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global IBS-C Drugs Market 2015-2019, by Type, in Volume
Figure Global IBS-C Drugs Market Growth 2015-2019, by Type, in Volume3.3 Market Forecast
Table Global IBS-C Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global IBS-C Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List4.1 Catalent Pharmaceuticals Solutions (Company Profile, Sales Data etc.)
4.1.1 Catalent Pharmaceuticals Solutions Profile
Table Catalent Pharmaceuticals Solutions Overview List
4.1.2 Catalent Pharmaceuticals Solutions Products & Services
4.1.3 Catalent Pharmaceuticals Solutions Business Operation Conditions
Table Business Operation of Catalent Pharmaceuticals Solutions (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.2 Nestle (Company Profile, Sales Data etc.)
4.2.1 Nestle Profile
Table Nestle Overview List
4.2.2 Nestle Products & Services
4.2.3 Nestle Business Operation Conditions
Table Business Operation of Nestle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.3 Abbott Laboratories (Company Profile, Sales Data etc.)
4.3.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
4.3.2 Abbott Laboratories Products & Services
4.3.3 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.4 Synergy Pharmaceuticals (Company Profile, Sales Data etc.)
4.4.1 Synergy Pharmaceuticals Profile
Table Synergy Pharmaceuticals Overview List
4.4.2 Synergy Pharmaceuticals Products & Services
4.4.3 Synergy Pharmaceuticals Business Operation Conditions
Table Business Operation of Synergy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.5 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
4.5.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
4.5.2 Sucampo Pharmaceuticals Products & Services
4.5.3 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)4.6 Novartis Pharma Ag (Company Profile, Sales Data etc.)
4.6.1 Novartis Pharma Ag Profile
Table Novartis Pharma Ag Overview List
4.6.2 Novartis Pharma Ag Products & Services
4.6.3 Novartis Pharma Ag Business Operation Conditions
Table Business Operation of Novartis Pharma Ag (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Astellas Pharmaceuticals (Company Profile, Sales Data etc.)
4.7.1 Astellas Pharmaceuticals Profile
Table Astellas Pharmaceuticals Overview List
4.7.2 Astellas Pharmaceuticals Products & Services
4.7.3 Astellas Pharmaceuticals Business Operation Conditions
Table Business Operation of Astellas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Ardelyx, Inc (Company Profile, Sales Data etc.)
4.8.1 Ardelyx, Inc Profile
Table Ardelyx, Inc Overview List
4.8.2 Ardelyx, Inc Products & Services
4.8.3 Ardelyx, Inc Business Operation Conditions
Table Business Operation of Ardelyx, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Synthetic Biologics, Inc (Company Profile, Sales Data etc.)
4.9.1 Synthetic Biologics, Inc Profile
Table Synthetic Biologics, Inc Overview List
4.9.2 Synthetic Biologics, Inc Products & Services
4.9.3 Synthetic Biologics, Inc Business Operation Conditions
Table Business Operation of Synthetic Biologics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva Pharmaceutical Industries (Company Profile, Sales Data etc.)
4.10.1 Teva Pharmaceutical Industries Profile
Table Teva Pharmaceutical Industries Overview List
4.10.2 Teva Pharmaceutical Industries Products & Services
4.10.3 Teva Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Bama-Geve, SLU (Company Profile, Sales Data etc.)
4.11.1 Bama-Geve, SLU Profile
Table Bama-Geve, SLU Overview List
4.11.2 Bama-Geve, SLU Products & Services
4.11.3 Bama-Geve, SLU Business Operation Conditions
Table Business Operation of Bama-Geve, SLU (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Ferring BV (Company Profile, Sales Data etc.)
4.12.1 Ferring BV Profile
Table Ferring BV Overview List
4.12.2 Ferring BV Products & Services
4.12.3 Ferring BV Business Operation Conditions
Table Business Operation of Ferring BV (Sales Revenue, Cost, Gross Margin)
4.13 Ironwood Pharmaceuticals, Inc (Company Profile, Sales Data etc.)
4.13.1 Ironwood Pharmaceuticals, Inc Profile
Table Ironwood Pharmaceuticals, Inc Overview List
4.13.2 Ironwood Pharmaceuticals, Inc Products & Services
4.13.3 Ironwood Pharmaceuticals, Inc Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Salix Pharmaceuticals Ltd (Company Profile, Sales Data etc.)
4.14.1 Salix Pharmaceuticals Ltd Profile
Table Salix Pharmaceuticals Ltd Overview List
4.14.2 Salix Pharmaceuticals Ltd Products & Services
4.14.3 Salix Pharmaceuticals Ltd Business Operation Conditions
Table Business Operation of Salix Pharmaceuticals Ltd (Sales Revenue, Cost, Gross Margin)
4.15 Norgine B.V (Company Profile, Sales Data etc.)
4.15.1 Norgine B.V Profile
Table Norgine B.V Overview List
4.15.2 Norgine B.V Products & Services
4.15.3 Norgine B.V Business Operation Conditions
Table Business Operation of Norgine B.V (Sales Revenue, Cost, Gross Margin)
4.16 Prometheus Laboratories Inc (Company Profile, Sales Data etc.)
4.16.1 Prometheus Laboratories Inc Profile
Table Prometheus Laboratories Inc Overview List
4.16.2 Prometheus Laboratories Inc Products & Services
4.16.3 Prometheus Laboratories Inc Business Operation Conditions
Table Business Operation of Prometheus Laboratories Inc (Sales Revenue, Cost, Gross Margin)
4.17 Actavis Nordic A/S (Company Profile, Sales Data etc.)
4.17.1 Actavis Nordic A/S Profile
Table Actavis Nordic A/S Overview List
4.17.2 Actavis Nordic A/S Products & Services
4.17.3 Actavis Nordic A/S Business Operation Conditions
Table Business Operation of Actavis Nordic A/S (Sales Revenue, Cost, Gross Margin)
4.18 Albireo Pharma Inc (Company Profile, Sales Data etc.)
4.18.1 Albireo Pharma Inc Profile
Table Albireo Pharma Inc Overview List
4.18.2 Albireo Pharma Inc Products & Services
4.18.3 Albireo Pharma Inc Business Operation Conditions
Table Business Operation of Albireo Pharma Inc (Sales Revenue, Cost, Gross Margin)
4.19 Yuhan Corp (Company Profile, Sales Data etc.)
4.19.1 Yuhan Corp Profile
Table Yuhan Corp Overview List
4.19.2 Yuhan Corp Products & Services
4.19.3 Yuhan Corp Business Operation Conditions
Table Business Operation of Yuhan Corp (Sales Revenue, Cost, Gross Margin)
4.20 Astrazeneca Plc (Company Profile, Sales Data etc.)
4.20.1 Astrazeneca Plc Profile
Table Astrazeneca Plc Overview List
4.20.2 Astrazeneca Plc Products & Services
4.20.3 Astrazeneca Plc Business Operation Conditions
Table Business Operation of Astrazeneca Plc (Sales Revenue, Cost, Gross Margin)
4.21 The Menarini Group (Company Profile, Sales Data etc.)
4.21.1 The Menarini Group Profile
Table The Menarini Group Overview List
4.21.2 The Menarini Group Products & Services
4.21.3 The Menarini Group Business Operation Conditions
Table Business Operation of The Menarini Group (Sales Revenue, Cost, Gross Margin)
4.22 Ono Pharmaceutical Co., Ltd (Company Profile, Sales Data etc.)
4.22.1 Ono Pharmaceutical Co., Ltd Profile
Table Ono Pharmaceutical Co., Ltd Overview List
4.22.2 Ono Pharmaceutical Co., Ltd Products & Services
4.22.3 Ono Pharmaceutical Co., Ltd Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Cost, Gross Margin)
5 Market Competition5.1 Company Competition
Table Global IBS-C Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global IBS-C Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global IBS-C Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global IBS-C Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global IBS-C Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global IBS-C Drugs Sales Volume Share in 2019, by Company, in Volume5.2 Regional Market by Company
Figure North America IBS-C Drugs Market Concentration, in 2019
Figure Europe IBS-C Drugs Market Market Concentration, in 2019
Figure Asia-Pacific IBS-C Drugs MMarket Concentration, in 2019
Figure South America IBS-C Drugs Market Concentration, in 2019
Figure Middle East & Africa IBS-C Drugs Market Concentration, in 2019
6 Demand by End Market6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
Figure IBS-C Drugs Demand in Hospital Pharmacies , 2015-2019, in USD Million
Figure IBS-C Drugs Demand in Hospital Pharmacies , 2015-2019, in Volume
6.1.2 Demand in Retail Pharmacies
Figure IBS-C Drugs Demand in Retail Pharmacies , 2015-2019, in USD Million
Figure IBS-C Drugs Demand in Retail Pharmacies , 2015-2019, in Volume
6.1.3 Demand in Online Pharmacies
Figure IBS-C Drugs Demand in Online Pharmacies, 2015-2019, in USD Million
Figure IBS-C Drugs Demand in Online Pharmacies, 2015-2019, in Volume6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions6.3 Demand Forecast
Table IBS-C Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure IBS-C Drugs Market Growth 2020-2025, by Application, in USD Million
Figure IBS-C Drugs Market Share in 2025, by Application, in USD Million
Table IBS-C Drugs Demand Forecast 2020-2025, by Application, in Volume
Table IBS-C Drugs Market Growth 2020-2025, by Application, in Volume
Table IBS-C Drugs Market Share in 2025, by Application, in Volume
7 Region Operation7.1 Regional Production
Table IBS-C Drugs Production 2015-2019, by Region, in USD Million
Table IBS-C Drugs Production 2015-2019, by Region, in Volume7.2 Regional Market
Table Global IBS-C Drugs Market 2015-2019, by Region, in USD Million
Table Global IBS-C Drugs Market Share 2015-2019, by Region, in USD Million
Table Global IBS-C Drugs Market 2015-2019, by Region, in Volume
Table Global IBS-C Drugs Market Share 2015-2019, by Region, in Volume7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America IBS-C Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
Table North America IBS-C Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe IBS-C Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe IBS-C Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific IBS-C Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific IBS-C Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America IBS-C Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
Table South America IBS-C Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa IBS-C Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa IBS-C Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa IBS-C Drugs Market Size 2015-2019, by Country, in Volume7.4 Regional Import & Export
7.5 Regional Forecast
Table IBS-C Drugs Market Forecast 2020-2025, by Region, in USD Million
Table IBS-C Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
-
The Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :














